nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—Lomustine—hematologic cancer	0.372	1	CrCtD
Carmustine—Alkylating Activity—Busulfan—hematologic cancer	0.0747	0.164	CiPCiCtD
Carmustine—Alkylating Activity—Lomustine—hematologic cancer	0.0566	0.124	CiPCiCtD
Carmustine—Alkylating Activity—Procarbazine—hematologic cancer	0.0566	0.124	CiPCiCtD
Carmustine—Alkylating Activity—Mechlorethamine—hematologic cancer	0.0566	0.124	CiPCiCtD
Carmustine—Alkylating Activity—Ifosfamide—hematologic cancer	0.0482	0.106	CiPCiCtD
Carmustine—Alkylating Activity—Melphalan—hematologic cancer	0.0429	0.0942	CiPCiCtD
Carmustine—Alkylating Activity—Thiotepa—hematologic cancer	0.0429	0.0942	CiPCiCtD
Carmustine—Alkylating Activity—Chlorambucil—hematologic cancer	0.0429	0.0942	CiPCiCtD
Carmustine—Alkylating Activity—Dacarbazine—hematologic cancer	0.0343	0.0753	CiPCiCtD
Carmustine—CYP1A2—Anagrelide—hematologic cancer	0.0191	0.245	CbGbCtD
Carmustine—CYP1A2—Methoxsalen—hematologic cancer	0.00853	0.109	CbGbCtD
Carmustine—CYP1A2—Bortezomib—hematologic cancer	0.00811	0.104	CbGbCtD
Carmustine—CYP1A2—Daunorubicin—hematologic cancer	0.00776	0.0996	CbGbCtD
Carmustine—CYP1A2—Alitretinoin—hematologic cancer	0.0076	0.0975	CbGbCtD
Carmustine—CYP1A2—Thalidomide—hematologic cancer	0.00707	0.0907	CbGbCtD
Carmustine—CYP1A2—Dacarbazine—hematologic cancer	0.00608	0.078	CbGbCtD
Carmustine—CYP1A2—Imatinib—hematologic cancer	0.00594	0.0763	CbGbCtD
Carmustine—CYP1A2—Dasatinib—hematologic cancer	0.00477	0.0613	CbGbCtD
Carmustine—CYP1A2—Etoposide—hematologic cancer	0.00297	0.0382	CbGbCtD
Carmustine—GSR—hematopoietic system—hematologic cancer	0.000923	0.187	CbGeAlD
Carmustine—GSR—gonad—hematologic cancer	0.000702	0.142	CbGeAlD
Carmustine—GSR—blood—hematologic cancer	0.000612	0.124	CbGeAlD
Carmustine—GSR—bone marrow—hematologic cancer	0.000592	0.12	CbGeAlD
Carmustine—GSR—lung—hematologic cancer	0.000536	0.109	CbGeAlD
Carmustine—GSR—testis—hematologic cancer	0.000506	0.102	CbGeAlD
Carmustine—GSR—lymph node—hematologic cancer	0.000367	0.0742	CbGeAlD
Carmustine—CYP1A2—hematopoietic system—hematologic cancer	0.000314	0.0635	CbGeAlD
Carmustine—CYP1A2—blood—hematologic cancer	0.000208	0.0421	CbGeAlD
Carmustine—CYP1A2—lung—hematologic cancer	0.000182	0.0369	CbGeAlD
Carmustine—GSR—NRF2 pathway—HSP90AA1—hematologic cancer	8.83e-05	0.00487	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—H3F3B—hematologic cancer	8.7e-05	0.0048	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—ICAM1—hematologic cancer	8.34e-05	0.0046	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—GSTP1—hematologic cancer	7.84e-05	0.00432	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—CCL2—hematologic cancer	7.47e-05	0.00412	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	7.28e-05	0.00401	CbGpPWpGaD
Carmustine—CYP1A2—Melatonin metabolism and effects—ARNTL—hematologic cancer	7.23e-05	0.00399	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—HGF—hematologic cancer	7.2e-05	0.00397	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—GSTM1—hematologic cancer	7.2e-05	0.00397	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—ALB—hematologic cancer	6.96e-05	0.00384	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—GSTP1—hematologic cancer	6.78e-05	0.00374	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CAMK2D—hematologic cancer	6.77e-05	0.00373	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—H3F3A—hematologic cancer	6.53e-05	0.0036	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—RET—hematologic cancer	6.42e-05	0.00354	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—IFNG—hematologic cancer	6.35e-05	0.0035	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—EPO—hematologic cancer	6.35e-05	0.0035	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—EZH2—hematologic cancer	6.26e-05	0.00345	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—GSTM1—hematologic cancer	6.23e-05	0.00343	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—PDGFB—hematologic cancer	6.19e-05	0.00341	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen metabolism—NQO1—hematologic cancer	6.17e-05	0.0034	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDK6—hematologic cancer	6.13e-05	0.00338	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	5.76e-05	0.00317	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—IL1B—hematologic cancer	5.66e-05	0.00312	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CYCS—hematologic cancer	5.53e-05	0.00305	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—HSP90AA1—hematologic cancer	5.5e-05	0.00303	CbGpPWpGaD
Carmustine—GSR—Metabolism—GMPS—hematologic cancer	5.27e-05	0.0029	CbGpPWpGaD
Carmustine—GSR—Metabolism—PHYH—hematologic cancer	5.27e-05	0.0029	CbGpPWpGaD
Carmustine—GSR—Metabolism—FTCD—hematologic cancer	5.27e-05	0.0029	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—GSTP1—hematologic cancer	4.88e-05	0.00269	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—ESR1—hematologic cancer	4.82e-05	0.00266	CbGpPWpGaD
Carmustine—GSR—Metabolism—SMPD3—hematologic cancer	4.82e-05	0.00266	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NCOR2—hematologic cancer	4.8e-05	0.00265	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen metabolism—GSTM1—hematologic cancer	4.73e-05	0.00261	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN2B—hematologic cancer	4.73e-05	0.00261	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—SOD2—hematologic cancer	4.5e-05	0.00248	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NF1—hematologic cancer	4.33e-05	0.00239	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—UGT1A1—hematologic cancer	4.25e-05	0.00234	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUND—hematologic cancer	4.25e-05	0.00234	CbGpPWpGaD
Carmustine—GSR—Metabolism—DCK—hematologic cancer	4.21e-05	0.00232	CbGpPWpGaD
Carmustine—GSR—Metabolism—ASNS—hematologic cancer	4.21e-05	0.00232	CbGpPWpGaD
Carmustine—GSR—Metabolism—B3GAT1—hematologic cancer	4.21e-05	0.00232	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—SLC35B2—hematologic cancer	4.18e-05	0.0023	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—TNF—hematologic cancer	4.11e-05	0.00227	CbGpPWpGaD
Carmustine—GSR—Metabolism—HDC—hematologic cancer	3.99e-05	0.0022	CbGpPWpGaD
Carmustine—CYP1A2—Arachidonic acid metabolism—ALOX5—hematologic cancer	3.77e-05	0.00208	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDK2—hematologic cancer	3.74e-05	0.00206	CbGpPWpGaD
Carmustine—GSR—Metabolism—CDA—hematologic cancer	3.65e-05	0.00201	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MAPK14—hematologic cancer	3.59e-05	0.00198	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—ATM—hematologic cancer	3.55e-05	0.00196	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDK4—hematologic cancer	3.54e-05	0.00195	CbGpPWpGaD
Carmustine—GSR—Metabolism—PC—hematologic cancer	3.51e-05	0.00194	CbGpPWpGaD
Carmustine—GSR—Metabolism—GBA—hematologic cancer	3.39e-05	0.00187	CbGpPWpGaD
Carmustine—GSR—Metabolism—SLC35B2—hematologic cancer	3.39e-05	0.00187	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—IL6—hematologic cancer	3.32e-05	0.00183	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—FOS—hematologic cancer	3.17e-05	0.00175	CbGpPWpGaD
Carmustine—CYP1A2—Melatonin metabolism and effects—FOXO1—hematologic cancer	3.15e-05	0.00173	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—JUN—hematologic cancer	3.12e-05	0.00172	CbGpPWpGaD
Carmustine—GSR—Metabolism—MTAP—hematologic cancer	3.1e-05	0.00171	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CREBBP—hematologic cancer	3.09e-05	0.0017	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—RB1—hematologic cancer	3.07e-05	0.0017	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—TGFB1—hematologic cancer	2.94e-05	0.00162	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	2.93e-05	0.00161	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—hematologic cancer	2.91e-05	0.00161	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—hematologic cancer	2.91e-05	0.00161	CbGpPWpGaD
Carmustine—GSR—Metabolism—FHL2—hematologic cancer	2.77e-05	0.00153	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HSP90AA1—hematologic cancer	2.74e-05	0.00151	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—HSP90AA1—hematologic cancer	2.74e-05	0.00151	CbGpPWpGaD
Carmustine—GSR—Metabolism—AGRN—hematologic cancer	2.71e-05	0.0015	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN2A—hematologic cancer	2.7e-05	0.00149	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—STAT3—hematologic cancer	2.7e-05	0.00149	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—GSTO1—hematologic cancer	2.69e-05	0.00148	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MDM2—hematologic cancer	2.62e-05	0.00145	CbGpPWpGaD
Carmustine—GSR—Metabolism—HMMR—hematologic cancer	2.57e-05	0.00142	CbGpPWpGaD
Carmustine—GSR—Metabolism—IDH2—hematologic cancer	2.57e-05	0.00142	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MTOR—hematologic cancer	2.55e-05	0.00141	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—UGT1A1—hematologic cancer	2.53e-05	0.00139	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—SLC35B2—hematologic cancer	2.44e-05	0.00135	CbGpPWpGaD
Carmustine—GSR—Metabolism—ARNTL—hematologic cancer	2.42e-05	0.00133	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—EPHX1—hematologic cancer	2.41e-05	0.00133	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN1B—hematologic cancer	2.39e-05	0.00132	CbGpPWpGaD
Carmustine—GSR—Metabolism—CA9—hematologic cancer	2.35e-05	0.0013	CbGpPWpGaD
Carmustine—GSR—Metabolism—ACP5—hematologic cancer	2.35e-05	0.0013	CbGpPWpGaD
Carmustine—GSR—Metabolism—NCOR2—hematologic cancer	2.32e-05	0.00128	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—JUN—hematologic cancer	2.28e-05	0.00126	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—hematologic cancer	2.25e-05	0.00124	CbGpPWpGaD
Carmustine—GSR—Metabolism—IDH1—hematologic cancer	2.21e-05	0.00122	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—CDKN1A—hematologic cancer	2.21e-05	0.00122	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—MTR—hematologic cancer	2.19e-05	0.00121	CbGpPWpGaD
Carmustine—GSR—Metabolism—TXN—hematologic cancer	2.19e-05	0.00121	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTO1—hematologic cancer	2.19e-05	0.00121	CbGpPWpGaD
Carmustine—GSR—Metabolism—ABCC3—hematologic cancer	2.19e-05	0.00121	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—hematologic cancer	2.18e-05	0.0012	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MAPK8—hematologic cancer	2.16e-05	0.00119	CbGpPWpGaD
Carmustine—GSR—Metabolism—SPHK1—hematologic cancer	2.14e-05	0.00118	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—EP300—hematologic cancer	2.1e-05	0.00116	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—GSTT1—hematologic cancer	2.09e-05	0.00115	CbGpPWpGaD
Carmustine—GSR—Metabolism—UGT1A1—hematologic cancer	2.06e-05	0.00113	CbGpPWpGaD
Carmustine—GSR—Metabolism—CRABP1—hematologic cancer	2e-05	0.0011	CbGpPWpGaD
Carmustine—GSR—Metabolism—SLC22A1—hematologic cancer	2e-05	0.0011	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—VEGFA—hematologic cancer	1.99e-05	0.0011	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—STAT3—hematologic cancer	1.97e-05	0.00109	CbGpPWpGaD
Carmustine—GSR—Metabolism—ALOX5—hematologic cancer	1.95e-05	0.00107	CbGpPWpGaD
Carmustine—GSR—Metabolism—NUP98—hematologic cancer	1.89e-05	0.00104	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MAPK3—hematologic cancer	1.88e-05	0.00104	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—hematologic cancer	1.86e-05	0.00103	CbGpPWpGaD
Carmustine—GSR—Metabolism—ADCY7—hematologic cancer	1.83e-05	0.00101	CbGpPWpGaD
Carmustine—GSR—Metabolism—NCOA3—hematologic cancer	1.83e-05	0.00101	CbGpPWpGaD
Carmustine—GSR—Metabolism—NUP214—hematologic cancer	1.82e-05	0.001	CbGpPWpGaD
Carmustine—GSR—Metabolism—ABCG2—hematologic cancer	1.78e-05	0.000983	CbGpPWpGaD
Carmustine—GSR—Metabolism—MTR—hematologic cancer	1.78e-05	0.000983	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—hematologic cancer	1.75e-05	0.000967	CbGpPWpGaD
Carmustine—GSR—Metabolism—ENO2—hematologic cancer	1.75e-05	0.000964	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTT1—hematologic cancer	1.7e-05	0.000935	CbGpPWpGaD
Carmustine—GSR—Metabolism—SDC1—hematologic cancer	1.66e-05	0.000914	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTO1—hematologic cancer	1.57e-05	0.000868	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTO1—hematologic cancer	1.55e-05	0.000856	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—hematologic cancer	1.53e-05	0.000844	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—TP53—hematologic cancer	1.5e-05	0.000829	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—UGT1A1—hematologic cancer	1.48e-05	0.000816	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—hematologic cancer	1.47e-05	0.000809	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—UGT1A1—hematologic cancer	1.46e-05	0.000805	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	1.46e-05	0.000802	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—GSTP1—hematologic cancer	1.45e-05	0.000797	CbGpPWpGaD
Carmustine—GSR—Metabolism—NQO1—hematologic cancer	1.41e-05	0.000777	CbGpPWpGaD
Carmustine—GSR—Metabolism—CD44—hematologic cancer	1.41e-05	0.000777	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—IL6—hematologic cancer	1.38e-05	0.000759	CbGpPWpGaD
Carmustine—GSR—Metabolism—CYCS—hematologic cancer	1.33e-05	0.000735	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	1.33e-05	0.000734	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—GSTM1—hematologic cancer	1.33e-05	0.000732	CbGpPWpGaD
Carmustine—GSR—Metabolism—HSP90AA1—hematologic cancer	1.33e-05	0.00073	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	1.31e-05	0.000724	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—MDM2—hematologic cancer	1.31e-05	0.00072	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—MTR—hematologic cancer	1.28e-05	0.000707	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTT1—hematologic cancer	1.22e-05	0.000673	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	1.19e-05	0.000657	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—hematologic cancer	1.19e-05	0.000657	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTP1—hematologic cancer	1.18e-05	0.000648	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	1.17e-05	0.000646	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	1.17e-05	0.000643	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	1.13e-05	0.000626	CbGpPWpGaD
Carmustine—GSR—Metabolism—ABCB1—hematologic cancer	1.11e-05	0.000613	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hematologic cancer	1.1e-05	0.000606	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTM1—hematologic cancer	1.08e-05	0.000595	CbGpPWpGaD
Carmustine—GSR—Metabolism—NCOR1—hematologic cancer	1.08e-05	0.000595	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	1.05e-05	0.000577	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—hematologic cancer	1.05e-05	0.000577	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—hematologic cancer	1.02e-05	0.000561	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	1.02e-05	0.000561	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	9.91e-06	0.000547	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	9.79e-06	0.00054	CbGpPWpGaD
Carmustine—GSR—Metabolism—MTHFR—hematologic cancer	9.55e-06	0.000526	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	9.38e-06	0.000517	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	9.12e-06	0.000503	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	9.1e-06	0.000502	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	8.5e-06	0.000468	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	8.5e-06	0.000468	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	8.46e-06	0.000466	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	8.43e-06	0.000465	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	8.34e-06	0.00046	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CG—hematologic cancer	8.02e-06	0.000442	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	7.77e-06	0.000429	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	7.67e-06	0.000423	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	7.65e-06	0.000421	CbGpPWpGaD
Carmustine—GSR—Metabolism—CREBBP—hematologic cancer	7.44e-06	0.00041	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	7.16e-06	0.000395	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CD—hematologic cancer	7.05e-06	0.000389	CbGpPWpGaD
Carmustine—GSR—Metabolism—ALB—hematologic cancer	6.96e-06	0.000384	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	6.68e-06	0.000368	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3R1—hematologic cancer	6.66e-06	0.000367	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GMPS—hematologic cancer	6.48e-06	0.000357	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—FTCD—hematologic cancer	6.48e-06	0.000357	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PHYH—hematologic cancer	6.48e-06	0.000357	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	6.42e-06	0.000354	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CB—hematologic cancer	6.15e-06	0.000339	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	6.11e-06	0.000337	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	6.04e-06	0.000333	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SMPD3—hematologic cancer	5.93e-06	0.000327	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	5.91e-06	0.000326	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	5.53e-06	0.000305	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	5.39e-06	0.000297	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTEN—hematologic cancer	5.31e-06	0.000293	CbGpPWpGaD
Carmustine—Connective tissue disorder—Epirubicin—hematologic cancer	5.23e-06	7.32e-05	CcSEcCtD
Carmustine—Headache—Vincristine—hematologic cancer	5.22e-06	7.3e-05	CcSEcCtD
Carmustine—Hypotension—Dexamethasone—hematologic cancer	5.19e-06	7.26e-05	CcSEcCtD
Carmustine—Hypotension—Betamethasone—hematologic cancer	5.19e-06	7.26e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—B3GAT1—hematologic cancer	5.18e-06	0.000286	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—DCK—hematologic cancer	5.18e-06	0.000286	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ASNS—hematologic cancer	5.18e-06	0.000286	CbGpPWpGaD
Carmustine—Vomiting—Mitoxantrone—hematologic cancer	5.16e-06	7.22e-05	CcSEcCtD
Carmustine—Vomiting—Irinotecan—hematologic cancer	5.16e-06	7.22e-05	CcSEcCtD
Carmustine—Nausea—Alitretinoin—hematologic cancer	5.13e-06	7.18e-05	CcSEcCtD
Carmustine—Convulsion—Prednisone—hematologic cancer	5.13e-06	7.18e-05	CcSEcCtD
Carmustine—Visual impairment—Epirubicin—hematologic cancer	5.13e-06	7.18e-05	CcSEcCtD
Carmustine—Hypertension—Prednisone—hematologic cancer	5.11e-06	7.16e-05	CcSEcCtD
Carmustine—Rash—Mitoxantrone—hematologic cancer	5.11e-06	7.16e-05	CcSEcCtD
Carmustine—Rash—Irinotecan—hematologic cancer	5.11e-06	7.16e-05	CcSEcCtD
Carmustine—Dermatitis—Mitoxantrone—hematologic cancer	5.11e-06	7.15e-05	CcSEcCtD
Carmustine—Dermatitis—Irinotecan—hematologic cancer	5.11e-06	7.15e-05	CcSEcCtD
Carmustine—Headache—Mitoxantrone—hematologic cancer	5.08e-06	7.11e-05	CcSEcCtD
Carmustine—Headache—Irinotecan—hematologic cancer	5.08e-06	7.11e-05	CcSEcCtD
Carmustine—Nausea—Ifosfamide—hematologic cancer	5.07e-06	7.1e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	5.06e-06	0.000279	CbGpPWpGaD
Carmustine—GSR—Metabolism—EP300—hematologic cancer	5.06e-06	0.000279	CbGpPWpGaD
Carmustine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.06e-06	7.08e-05	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.06e-06	7.08e-05	CcSEcCtD
Carmustine—Myalgia—Prednisone—hematologic cancer	5.04e-06	7.06e-05	CcSEcCtD
Carmustine—Feeling abnormal—Triamcinolone—hematologic cancer	5.04e-06	7.06e-05	CcSEcCtD
Carmustine—Diarrhoea—Cisplatin—hematologic cancer	5.04e-06	7.05e-05	CcSEcCtD
Carmustine—Anxiety—Prednisone—hematologic cancer	5.03e-06	7.03e-05	CcSEcCtD
Carmustine—Alopecia—Methotrexate—hematologic cancer	5.03e-06	7.03e-05	CcSEcCtD
Carmustine—Vomiting—Gemcitabine—hematologic cancer	5.02e-06	7.03e-05	CcSEcCtD
Carmustine—Insomnia—Dexamethasone—hematologic cancer	5.02e-06	7.03e-05	CcSEcCtD
Carmustine—Insomnia—Betamethasone—hematologic cancer	5.02e-06	7.03e-05	CcSEcCtD
Carmustine—Paraesthesia—Dexamethasone—hematologic cancer	4.99e-06	6.98e-05	CcSEcCtD
Carmustine—Paraesthesia—Betamethasone—hematologic cancer	4.99e-06	6.98e-05	CcSEcCtD
Carmustine—Mental disorder—Methotrexate—hematologic cancer	4.98e-06	6.97e-05	CcSEcCtD
Carmustine—Rash—Gemcitabine—hematologic cancer	4.98e-06	6.97e-05	CcSEcCtD
Carmustine—Dermatitis—Gemcitabine—hematologic cancer	4.98e-06	6.96e-05	CcSEcCtD
Carmustine—Eye disorder—Epirubicin—hematologic cancer	4.97e-06	6.96e-05	CcSEcCtD
Carmustine—Hypersensitivity—Etoposide—hematologic cancer	4.97e-06	6.96e-05	CcSEcCtD
Carmustine—Erythema—Methotrexate—hematologic cancer	4.95e-06	6.93e-05	CcSEcCtD
Carmustine—Malnutrition—Methotrexate—hematologic cancer	4.95e-06	6.93e-05	CcSEcCtD
Carmustine—Haemoglobin—Doxorubicin—hematologic cancer	4.95e-06	6.93e-05	CcSEcCtD
Carmustine—Headache—Gemcitabine—hematologic cancer	4.95e-06	6.93e-05	CcSEcCtD
Carmustine—Nausea—Vincristine—hematologic cancer	4.95e-06	6.92e-05	CcSEcCtD
Carmustine—Flushing—Epirubicin—hematologic cancer	4.94e-06	6.91e-05	CcSEcCtD
Carmustine—Haemorrhage—Doxorubicin—hematologic cancer	4.92e-06	6.89e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—HDC—hematologic cancer	4.91e-06	0.000271	CbGpPWpGaD
Carmustine—Hypersensitivity—Prednisolone—hematologic cancer	4.9e-06	6.86e-05	CcSEcCtD
Carmustine—Hypoaesthesia—Doxorubicin—hematologic cancer	4.9e-06	6.86e-05	CcSEcCtD
Carmustine—Oedema peripheral—Doxorubicin—hematologic cancer	4.85e-06	6.79e-05	CcSEcCtD
Carmustine—Asthenia—Etoposide—hematologic cancer	4.84e-06	6.77e-05	CcSEcCtD
Carmustine—Connective tissue disorder—Doxorubicin—hematologic cancer	4.84e-06	6.77e-05	CcSEcCtD
Carmustine—Body temperature increased—Triamcinolone—hematologic cancer	4.84e-06	6.77e-05	CcSEcCtD
Carmustine—Oedema—Prednisone—hematologic cancer	4.83e-06	6.77e-05	CcSEcCtD
Carmustine—Decreased appetite—Dexamethasone—hematologic cancer	4.83e-06	6.75e-05	CcSEcCtD
Carmustine—Decreased appetite—Betamethasone—hematologic cancer	4.83e-06	6.75e-05	CcSEcCtD
Carmustine—Nausea—Mitoxantrone—hematologic cancer	4.82e-06	6.74e-05	CcSEcCtD
Carmustine—Nausea—Irinotecan—hematologic cancer	4.82e-06	6.74e-05	CcSEcCtD
Carmustine—Infection—Prednisone—hematologic cancer	4.8e-06	6.72e-05	CcSEcCtD
Carmustine—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.79e-06	6.71e-05	CcSEcCtD
Carmustine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.79e-06	6.71e-05	CcSEcCtD
Carmustine—Back pain—Methotrexate—hematologic cancer	4.79e-06	6.7e-05	CcSEcCtD
Carmustine—Arrhythmia—Epirubicin—hematologic cancer	4.75e-06	6.65e-05	CcSEcCtD
Carmustine—Pain—Betamethasone—hematologic cancer	4.75e-06	6.64e-05	CcSEcCtD
Carmustine—Pain—Dexamethasone—hematologic cancer	4.75e-06	6.64e-05	CcSEcCtD
Carmustine—Visual impairment—Doxorubicin—hematologic cancer	4.75e-06	6.64e-05	CcSEcCtD
Carmustine—Tachycardia—Prednisone—hematologic cancer	4.72e-06	6.6e-05	CcSEcCtD
Carmustine—Alopecia—Epirubicin—hematologic cancer	4.7e-06	6.58e-05	CcSEcCtD
Carmustine—Nausea—Gemcitabine—hematologic cancer	4.69e-06	6.57e-05	CcSEcCtD
Carmustine—Vomiting—Cisplatin—hematologic cancer	4.68e-06	6.55e-05	CcSEcCtD
Carmustine—Vision blurred—Methotrexate—hematologic cancer	4.67e-06	6.53e-05	CcSEcCtD
Carmustine—Mental disorder—Epirubicin—hematologic cancer	4.66e-06	6.53e-05	CcSEcCtD
Carmustine—Rash—Cisplatin—hematologic cancer	4.64e-06	6.5e-05	CcSEcCtD
Carmustine—Dermatitis—Cisplatin—hematologic cancer	4.64e-06	6.49e-05	CcSEcCtD
Carmustine—Erythema—Epirubicin—hematologic cancer	4.63e-06	6.48e-05	CcSEcCtD
Carmustine—Malnutrition—Epirubicin—hematologic cancer	4.63e-06	6.48e-05	CcSEcCtD
Carmustine—Diarrhoea—Etoposide—hematologic cancer	4.62e-06	6.46e-05	CcSEcCtD
Carmustine—Anorexia—Prednisone—hematologic cancer	4.61e-06	6.45e-05	CcSEcCtD
Carmustine—Eye disorder—Doxorubicin—hematologic cancer	4.6e-06	6.44e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	4.58e-06	0.000252	CbGpPWpGaD
Carmustine—Anaemia—Methotrexate—hematologic cancer	4.58e-06	6.4e-05	CcSEcCtD
Carmustine—Feeling abnormal—Betamethasone—hematologic cancer	4.57e-06	6.4e-05	CcSEcCtD
Carmustine—Feeling abnormal—Dexamethasone—hematologic cancer	4.57e-06	6.4e-05	CcSEcCtD
Carmustine—Flushing—Doxorubicin—hematologic cancer	4.57e-06	6.4e-05	CcSEcCtD
Carmustine—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.54e-06	6.35e-05	CcSEcCtD
Carmustine—Gastrointestinal pain—Betamethasone—hematologic cancer	4.54e-06	6.35e-05	CcSEcCtD
Carmustine—Hypersensitivity—Triamcinolone—hematologic cancer	4.51e-06	6.31e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—CDA—hematologic cancer	4.49e-06	0.000248	CbGpPWpGaD
Carmustine—Back pain—Epirubicin—hematologic cancer	4.48e-06	6.27e-05	CcSEcCtD
Carmustine—Dizziness—Etoposide—hematologic cancer	4.46e-06	6.24e-05	CcSEcCtD
Carmustine—Leukopenia—Methotrexate—hematologic cancer	4.43e-06	6.2e-05	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.4e-06	6.16e-05	CcSEcCtD
Carmustine—Dizziness—Prednisolone—hematologic cancer	4.4e-06	6.16e-05	CcSEcCtD
Carmustine—Arrhythmia—Doxorubicin—hematologic cancer	4.4e-06	6.16e-05	CcSEcCtD
Carmustine—Asthenia—Triamcinolone—hematologic cancer	4.39e-06	6.14e-05	CcSEcCtD
Carmustine—Abdominal pain—Betamethasone—hematologic cancer	4.39e-06	6.14e-05	CcSEcCtD
Carmustine—Body temperature increased—Dexamethasone—hematologic cancer	4.39e-06	6.14e-05	CcSEcCtD
Carmustine—Abdominal pain—Dexamethasone—hematologic cancer	4.39e-06	6.14e-05	CcSEcCtD
Carmustine—Body temperature increased—Betamethasone—hematologic cancer	4.39e-06	6.14e-05	CcSEcCtD
Carmustine—Nausea—Cisplatin—hematologic cancer	4.37e-06	6.12e-05	CcSEcCtD
Carmustine—Insomnia—Prednisone—hematologic cancer	4.37e-06	6.12e-05	CcSEcCtD
Carmustine—Vision blurred—Epirubicin—hematologic cancer	4.37e-06	6.11e-05	CcSEcCtD
Carmustine—Alopecia—Doxorubicin—hematologic cancer	4.35e-06	6.09e-05	CcSEcCtD
Carmustine—Paraesthesia—Prednisone—hematologic cancer	4.34e-06	6.08e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—PC—hematologic cancer	4.32e-06	0.000238	CbGpPWpGaD
Carmustine—Mental disorder—Doxorubicin—hematologic cancer	4.31e-06	6.04e-05	CcSEcCtD
Carmustine—Convulsion—Methotrexate—hematologic cancer	4.29e-06	6e-05	CcSEcCtD
Carmustine—Vomiting—Etoposide—hematologic cancer	4.29e-06	6e-05	CcSEcCtD
Carmustine—Erythema—Doxorubicin—hematologic cancer	4.29e-06	6e-05	CcSEcCtD
Carmustine—Malnutrition—Doxorubicin—hematologic cancer	4.29e-06	6e-05	CcSEcCtD
Carmustine—Anaemia—Epirubicin—hematologic cancer	4.28e-06	5.99e-05	CcSEcCtD
Carmustine—Agitation—Epirubicin—hematologic cancer	4.26e-06	5.96e-05	CcSEcCtD
Carmustine—Rash—Etoposide—hematologic cancer	4.25e-06	5.95e-05	CcSEcCtD
Carmustine—Dermatitis—Etoposide—hematologic cancer	4.25e-06	5.95e-05	CcSEcCtD
Carmustine—Headache—Etoposide—hematologic cancer	4.23e-06	5.91e-05	CcSEcCtD
Carmustine—Myalgia—Methotrexate—hematologic cancer	4.21e-06	5.9e-05	CcSEcCtD
Carmustine—Chest pain—Methotrexate—hematologic cancer	4.21e-06	5.9e-05	CcSEcCtD
Carmustine—Decreased appetite—Prednisone—hematologic cancer	4.2e-06	5.88e-05	CcSEcCtD
Carmustine—Rash—Prednisolone—hematologic cancer	4.2e-06	5.87e-05	CcSEcCtD
Carmustine—Dermatitis—Prednisolone—hematologic cancer	4.19e-06	5.87e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—SLC35B2—hematologic cancer	4.18e-06	0.00023	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GBA—hematologic cancer	4.18e-06	0.00023	CbGpPWpGaD
Carmustine—Headache—Prednisolone—hematologic cancer	4.17e-06	5.83e-05	CcSEcCtD
Carmustine—Leukopenia—Epirubicin—hematologic cancer	4.15e-06	5.8e-05	CcSEcCtD
Carmustine—Back pain—Doxorubicin—hematologic cancer	4.15e-06	5.8e-05	CcSEcCtD
Carmustine—Constipation—Prednisone—hematologic cancer	4.13e-06	5.79e-05	CcSEcCtD
Carmustine—Confusional state—Methotrexate—hematologic cancer	4.07e-06	5.7e-05	CcSEcCtD
Carmustine—Dizziness—Triamcinolone—hematologic cancer	4.05e-06	5.66e-05	CcSEcCtD
Carmustine—Vision blurred—Doxorubicin—hematologic cancer	4.04e-06	5.65e-05	CcSEcCtD
Carmustine—Convulsion—Epirubicin—hematologic cancer	4.01e-06	5.62e-05	CcSEcCtD
Carmustine—Infection—Methotrexate—hematologic cancer	4.01e-06	5.62e-05	CcSEcCtD
Carmustine—Nausea—Etoposide—hematologic cancer	4.01e-06	5.61e-05	CcSEcCtD
Carmustine—Hypertension—Epirubicin—hematologic cancer	4e-06	5.6e-05	CcSEcCtD
Carmustine—Feeling abnormal—Prednisone—hematologic cancer	3.98e-06	5.58e-05	CcSEcCtD
Carmustine—Asthenia—Betamethasone—hematologic cancer	3.98e-06	5.57e-05	CcSEcCtD
Carmustine—Asthenia—Dexamethasone—hematologic cancer	3.98e-06	5.57e-05	CcSEcCtD
Carmustine—Anaemia—Doxorubicin—hematologic cancer	3.96e-06	5.55e-05	CcSEcCtD
Carmustine—Thrombocytopenia—Methotrexate—hematologic cancer	3.96e-06	5.54e-05	CcSEcCtD
Carmustine—Gastrointestinal pain—Prednisone—hematologic cancer	3.95e-06	5.53e-05	CcSEcCtD
Carmustine—Nausea—Prednisolone—hematologic cancer	3.95e-06	5.53e-05	CcSEcCtD
Carmustine—Chest pain—Epirubicin—hematologic cancer	3.94e-06	5.52e-05	CcSEcCtD
Carmustine—Myalgia—Epirubicin—hematologic cancer	3.94e-06	5.52e-05	CcSEcCtD
Carmustine—Agitation—Doxorubicin—hematologic cancer	3.94e-06	5.51e-05	CcSEcCtD
Carmustine—Anxiety—Epirubicin—hematologic cancer	3.93e-06	5.5e-05	CcSEcCtD
Carmustine—Vomiting—Triamcinolone—hematologic cancer	3.89e-06	5.44e-05	CcSEcCtD
Carmustine—Rash—Triamcinolone—hematologic cancer	3.86e-06	5.4e-05	CcSEcCtD
Carmustine—Dermatitis—Triamcinolone—hematologic cancer	3.85e-06	5.39e-05	CcSEcCtD
Carmustine—Anorexia—Methotrexate—hematologic cancer	3.85e-06	5.39e-05	CcSEcCtD
Carmustine—Leukopenia—Doxorubicin—hematologic cancer	3.84e-06	5.37e-05	CcSEcCtD
Carmustine—Headache—Triamcinolone—hematologic cancer	3.83e-06	5.36e-05	CcSEcCtD
Carmustine—Body temperature increased—Prednisone—hematologic cancer	3.82e-06	5.35e-05	CcSEcCtD
Carmustine—Abdominal pain—Prednisone—hematologic cancer	3.82e-06	5.35e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—MTAP—hematologic cancer	3.82e-06	0.000211	CbGpPWpGaD
Carmustine—Confusional state—Epirubicin—hematologic cancer	3.81e-06	5.34e-05	CcSEcCtD
Carmustine—Diarrhoea—Dexamethasone—hematologic cancer	3.8e-06	5.32e-05	CcSEcCtD
Carmustine—Diarrhoea—Betamethasone—hematologic cancer	3.8e-06	5.32e-05	CcSEcCtD
Carmustine—Oedema—Epirubicin—hematologic cancer	3.78e-06	5.29e-05	CcSEcCtD
Carmustine—Hypotension—Methotrexate—hematologic cancer	3.78e-06	5.28e-05	CcSEcCtD
Carmustine—Infection—Epirubicin—hematologic cancer	3.76e-06	5.26e-05	CcSEcCtD
Carmustine—GSR—Metabolism—PIK3CA—hematologic cancer	3.75e-06	0.000207	CbGpPWpGaD
Carmustine—Convulsion—Doxorubicin—hematologic cancer	3.71e-06	5.2e-05	CcSEcCtD
Carmustine—Thrombocytopenia—Epirubicin—hematologic cancer	3.7e-06	5.18e-05	CcSEcCtD
Carmustine—Hypertension—Doxorubicin—hematologic cancer	3.7e-06	5.18e-05	CcSEcCtD
Carmustine—Tachycardia—Epirubicin—hematologic cancer	3.69e-06	5.16e-05	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.68e-06	5.15e-05	CcSEcCtD
Carmustine—Dizziness—Betamethasone—hematologic cancer	3.67e-06	5.14e-05	CcSEcCtD
Carmustine—Dizziness—Dexamethasone—hematologic cancer	3.67e-06	5.14e-05	CcSEcCtD
Carmustine—Insomnia—Methotrexate—hematologic cancer	3.65e-06	5.11e-05	CcSEcCtD
Carmustine—Chest pain—Doxorubicin—hematologic cancer	3.65e-06	5.11e-05	CcSEcCtD
Carmustine—Myalgia—Doxorubicin—hematologic cancer	3.65e-06	5.11e-05	CcSEcCtD
Carmustine—Anxiety—Doxorubicin—hematologic cancer	3.64e-06	5.09e-05	CcSEcCtD
Carmustine—Nausea—Triamcinolone—hematologic cancer	3.63e-06	5.09e-05	CcSEcCtD
Carmustine—Paraesthesia—Methotrexate—hematologic cancer	3.63e-06	5.08e-05	CcSEcCtD
Carmustine—Anorexia—Epirubicin—hematologic cancer	3.6e-06	5.04e-05	CcSEcCtD
Carmustine—Dyspnoea—Methotrexate—hematologic cancer	3.6e-06	5.04e-05	CcSEcCtD
Carmustine—Somnolence—Methotrexate—hematologic cancer	3.59e-06	5.03e-05	CcSEcCtD
Carmustine—Hypersensitivity—Prednisone—hematologic cancer	3.56e-06	4.99e-05	CcSEcCtD
Carmustine—Hypotension—Epirubicin—hematologic cancer	3.53e-06	4.95e-05	CcSEcCtD
Carmustine—Vomiting—Betamethasone—hematologic cancer	3.53e-06	4.94e-05	CcSEcCtD
Carmustine—Vomiting—Dexamethasone—hematologic cancer	3.53e-06	4.94e-05	CcSEcCtD
Carmustine—Confusional state—Doxorubicin—hematologic cancer	3.53e-06	4.94e-05	CcSEcCtD
Carmustine—Decreased appetite—Methotrexate—hematologic cancer	3.51e-06	4.92e-05	CcSEcCtD
Carmustine—Rash—Betamethasone—hematologic cancer	3.5e-06	4.9e-05	CcSEcCtD
Carmustine—Rash—Dexamethasone—hematologic cancer	3.5e-06	4.9e-05	CcSEcCtD
Carmustine—Oedema—Doxorubicin—hematologic cancer	3.5e-06	4.9e-05	CcSEcCtD
Carmustine—Dermatitis—Dexamethasone—hematologic cancer	3.5e-06	4.89e-05	CcSEcCtD
Carmustine—Dermatitis—Betamethasone—hematologic cancer	3.5e-06	4.89e-05	CcSEcCtD
Carmustine—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.49e-06	4.88e-05	CcSEcCtD
Carmustine—Headache—Betamethasone—hematologic cancer	3.48e-06	4.87e-05	CcSEcCtD
Carmustine—Headache—Dexamethasone—hematologic cancer	3.48e-06	4.87e-05	CcSEcCtD
Carmustine—Infection—Doxorubicin—hematologic cancer	3.48e-06	4.86e-05	CcSEcCtD
Carmustine—Asthenia—Prednisone—hematologic cancer	3.47e-06	4.85e-05	CcSEcCtD
Carmustine—Pain—Methotrexate—hematologic cancer	3.46e-06	4.84e-05	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.45e-06	4.82e-05	CcSEcCtD
Carmustine—Thrombocytopenia—Doxorubicin—hematologic cancer	3.43e-06	4.79e-05	CcSEcCtD
Carmustine—Insomnia—Epirubicin—hematologic cancer	3.42e-06	4.79e-05	CcSEcCtD
Carmustine—Tachycardia—Doxorubicin—hematologic cancer	3.41e-06	4.78e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—FHL2—hematologic cancer	3.41e-06	0.000188	CbGpPWpGaD
Carmustine—Paraesthesia—Epirubicin—hematologic cancer	3.4e-06	4.75e-05	CcSEcCtD
Carmustine—Dyspnoea—Epirubicin—hematologic cancer	3.37e-06	4.72e-05	CcSEcCtD
Carmustine—Somnolence—Epirubicin—hematologic cancer	3.36e-06	4.7e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—AGRN—hematologic cancer	3.34e-06	0.000184	CbGpPWpGaD
Carmustine—Anorexia—Doxorubicin—hematologic cancer	3.34e-06	4.67e-05	CcSEcCtD
Carmustine—Feeling abnormal—Methotrexate—hematologic cancer	3.33e-06	4.66e-05	CcSEcCtD
Carmustine—Diarrhoea—Prednisone—hematologic cancer	3.31e-06	4.63e-05	CcSEcCtD
Carmustine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.3e-06	4.62e-05	CcSEcCtD
Carmustine—Nausea—Betamethasone—hematologic cancer	3.3e-06	4.62e-05	CcSEcCtD
Carmustine—Nausea—Dexamethasone—hematologic cancer	3.3e-06	4.62e-05	CcSEcCtD
Carmustine—Decreased appetite—Epirubicin—hematologic cancer	3.29e-06	4.6e-05	CcSEcCtD
Carmustine—Hypotension—Doxorubicin—hematologic cancer	3.27e-06	4.58e-05	CcSEcCtD
Carmustine—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.26e-06	4.57e-05	CcSEcCtD
Carmustine—Constipation—Epirubicin—hematologic cancer	3.23e-06	4.53e-05	CcSEcCtD
Carmustine—Pain—Epirubicin—hematologic cancer	3.23e-06	4.53e-05	CcSEcCtD
Carmustine—Dizziness—Prednisone—hematologic cancer	3.2e-06	4.47e-05	CcSEcCtD
Carmustine—Body temperature increased—Methotrexate—hematologic cancer	3.19e-06	4.47e-05	CcSEcCtD
Carmustine—Abdominal pain—Methotrexate—hematologic cancer	3.19e-06	4.47e-05	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.19e-06	4.46e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—HMMR—hematologic cancer	3.17e-06	0.000175	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—IDH2—hematologic cancer	3.17e-06	0.000175	CbGpPWpGaD
Carmustine—Insomnia—Doxorubicin—hematologic cancer	3.16e-06	4.43e-05	CcSEcCtD
Carmustine—Paraesthesia—Doxorubicin—hematologic cancer	3.14e-06	4.4e-05	CcSEcCtD
Carmustine—Dyspnoea—Doxorubicin—hematologic cancer	3.12e-06	4.37e-05	CcSEcCtD
Carmustine—Feeling abnormal—Epirubicin—hematologic cancer	3.12e-06	4.36e-05	CcSEcCtD
Carmustine—Somnolence—Doxorubicin—hematologic cancer	3.11e-06	4.35e-05	CcSEcCtD
Carmustine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.09e-06	4.33e-05	CcSEcCtD
Carmustine—Vomiting—Prednisone—hematologic cancer	3.07e-06	4.3e-05	CcSEcCtD
Carmustine—GSR—Metabolism—AKT1—hematologic cancer	3.06e-06	0.000169	CbGpPWpGaD
Carmustine—Rash—Prednisone—hematologic cancer	3.05e-06	4.27e-05	CcSEcCtD
Carmustine—Dermatitis—Prednisone—hematologic cancer	3.05e-06	4.26e-05	CcSEcCtD
Carmustine—Decreased appetite—Doxorubicin—hematologic cancer	3.04e-06	4.26e-05	CcSEcCtD
Carmustine—Headache—Prednisone—hematologic cancer	3.03e-06	4.24e-05	CcSEcCtD
Carmustine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.02e-06	4.23e-05	CcSEcCtD
Carmustine—Constipation—Doxorubicin—hematologic cancer	2.99e-06	4.19e-05	CcSEcCtD
Carmustine—Pain—Doxorubicin—hematologic cancer	2.99e-06	4.19e-05	CcSEcCtD
Carmustine—Body temperature increased—Epirubicin—hematologic cancer	2.99e-06	4.18e-05	CcSEcCtD
Carmustine—Abdominal pain—Epirubicin—hematologic cancer	2.99e-06	4.18e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.99e-06	0.000165	CbGpPWpGaD
Carmustine—Hypersensitivity—Methotrexate—hematologic cancer	2.98e-06	4.17e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—ARNTL—hematologic cancer	2.98e-06	0.000164	CbGpPWpGaD
Carmustine—Asthenia—Methotrexate—hematologic cancer	2.9e-06	4.06e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—ACP5—hematologic cancer	2.9e-06	0.00016	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CA9—hematologic cancer	2.9e-06	0.00016	CbGpPWpGaD
Carmustine—Feeling abnormal—Doxorubicin—hematologic cancer	2.88e-06	4.04e-05	CcSEcCtD
Carmustine—Nausea—Prednisone—hematologic cancer	2.87e-06	4.02e-05	CcSEcCtD
Carmustine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.86e-06	4e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—NCOR2—hematologic cancer	2.86e-06	0.000158	CbGpPWpGaD
Carmustine—Hypersensitivity—Epirubicin—hematologic cancer	2.79e-06	3.9e-05	CcSEcCtD
Carmustine—Body temperature increased—Doxorubicin—hematologic cancer	2.77e-06	3.87e-05	CcSEcCtD
Carmustine—Abdominal pain—Doxorubicin—hematologic cancer	2.77e-06	3.87e-05	CcSEcCtD
Carmustine—Diarrhoea—Methotrexate—hematologic cancer	2.76e-06	3.87e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—IDH1—hematologic cancer	2.72e-06	0.00015	CbGpPWpGaD
Carmustine—Asthenia—Epirubicin—hematologic cancer	2.71e-06	3.8e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—TXN—hematologic cancer	2.69e-06	0.000148	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCC3—hematologic cancer	2.69e-06	0.000148	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTO1—hematologic cancer	2.69e-06	0.000148	CbGpPWpGaD
Carmustine—Dizziness—Methotrexate—hematologic cancer	2.67e-06	3.74e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—SPHK1—hematologic cancer	2.63e-06	0.000145	CbGpPWpGaD
Carmustine—Diarrhoea—Epirubicin—hematologic cancer	2.59e-06	3.62e-05	CcSEcCtD
Carmustine—Hypersensitivity—Doxorubicin—hematologic cancer	2.58e-06	3.61e-05	CcSEcCtD
Carmustine—Vomiting—Methotrexate—hematologic cancer	2.57e-06	3.6e-05	CcSEcCtD
Carmustine—Rash—Methotrexate—hematologic cancer	2.55e-06	3.57e-05	CcSEcCtD
Carmustine—Dermatitis—Methotrexate—hematologic cancer	2.55e-06	3.56e-05	CcSEcCtD
Carmustine—Headache—Methotrexate—hematologic cancer	2.53e-06	3.54e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	2.53e-06	0.00014	CbGpPWpGaD
Carmustine—Asthenia—Doxorubicin—hematologic cancer	2.51e-06	3.51e-05	CcSEcCtD
Carmustine—Dizziness—Epirubicin—hematologic cancer	2.5e-06	3.5e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	2.46e-06	0.000136	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CRABP1—hematologic cancer	2.46e-06	0.000136	CbGpPWpGaD
Carmustine—Vomiting—Epirubicin—hematologic cancer	2.4e-06	3.36e-05	CcSEcCtD
Carmustine—Nausea—Methotrexate—hematologic cancer	2.4e-06	3.36e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—ALOX5—hematologic cancer	2.4e-06	0.000132	CbGpPWpGaD
Carmustine—Diarrhoea—Doxorubicin—hematologic cancer	2.39e-06	3.35e-05	CcSEcCtD
Carmustine—Rash—Epirubicin—hematologic cancer	2.38e-06	3.34e-05	CcSEcCtD
Carmustine—Dermatitis—Epirubicin—hematologic cancer	2.38e-06	3.33e-05	CcSEcCtD
Carmustine—Headache—Epirubicin—hematologic cancer	2.37e-06	3.32e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—NUP98—hematologic cancer	2.32e-06	0.000128	CbGpPWpGaD
Carmustine—Dizziness—Doxorubicin—hematologic cancer	2.31e-06	3.24e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—ADCY7—hematologic cancer	2.26e-06	0.000124	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NCOA3—hematologic cancer	2.26e-06	0.000124	CbGpPWpGaD
Carmustine—Nausea—Epirubicin—hematologic cancer	2.25e-06	3.14e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—NUP214—hematologic cancer	2.24e-06	0.000123	CbGpPWpGaD
Carmustine—Vomiting—Doxorubicin—hematologic cancer	2.22e-06	3.11e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.22e-06	0.000122	CbGpPWpGaD
Carmustine—Rash—Doxorubicin—hematologic cancer	2.21e-06	3.09e-05	CcSEcCtD
Carmustine—Dermatitis—Doxorubicin—hematologic cancer	2.2e-06	3.08e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—ABCG2—hematologic cancer	2.19e-06	0.000121	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MTR—hematologic cancer	2.19e-06	0.000121	CbGpPWpGaD
Carmustine—Headache—Doxorubicin—hematologic cancer	2.19e-06	3.07e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism—ENO2—hematologic cancer	2.15e-06	0.000119	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTT1—hematologic cancer	2.09e-06	0.000115	CbGpPWpGaD
Carmustine—Nausea—Doxorubicin—hematologic cancer	2.08e-06	2.91e-05	CcSEcCtD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.06e-06	0.000113	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SDC1—hematologic cancer	2.04e-06	0.000112	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.95e-06	0.000107	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.92e-06	0.000106	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.84e-06	0.000101	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CD44—hematologic cancer	1.73e-06	9.56e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NQO1—hematologic cancer	1.73e-06	9.56e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.7e-06	9.36e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYCS—hematologic cancer	1.64e-06	9.05e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.63e-06	8.99e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.47e-06	8.09e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.45e-06	7.97e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.4e-06	7.72e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.37e-06	7.55e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.33e-06	7.33e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.33e-06	7.33e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.17e-06	6.48e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.04e-06	5.71e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	9.87e-07	5.44e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CREBBP—hematologic cancer	9.15e-07	5.05e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	8.68e-07	4.78e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ALB—hematologic cancer	8.57e-07	4.72e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	8.19e-07	4.52e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	7.56e-07	4.17e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTEN—hematologic cancer	6.54e-07	3.6e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—EP300—hematologic cancer	6.23e-07	3.44e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	4.61e-07	2.54e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKT1—hematologic cancer	3.77e-07	2.08e-05	CbGpPWpGaD
